Life Science Leader Magazine Supplements

CMO 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/792774

Contents of this Issue

Navigation

Page 59 of 81

CAPABILITIES COMPATIBILITY DEVELOPMENT EXPERTISE RELIABILITY K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2017 CMO LEADERSHIP AWARDS WINNERS 58 LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 QUALITY Company Profiles DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: drug development & manufacturing services for oral solid dose, liquids, powders, gels & semisolids, with specialization of contained manufacture of potent compounds. Packaging & distribution services for all delivery forms including oral solid dose, liquids & pow- ders, as well as parenteral delivery forms includ- ing ampoules, vials, syringes & injectable devices. "At PCI Pharma Services, our #1 commitment is to provide the industry's leading customer experi- ence. We hold ourselves to the highest standards and focus on demonstrating a true partnership model with our customers, striving to be a seam- less extension of their supply chains. We are very grateful to be recognized for such a prestigious award and further trusted to be the supplier of choice to the leading pharmaceutical and biotech companies around the world." DRUG TYPE: Pharmaceuticals BILL MITCHELL President & CEO CATEGORIES WON: PCI Pharma Services Philadelphia, PA www.pciservices.com Phone: +1 215 613 3600 Contact: Justin Schroeder Email: justin.schroeder@pciservices.com Key locations: Philadelphia, PA, USA; Rockford, IL, USA; Woodstock, IL, USA; Tredegar, UK; Bridgend, UK; Hay-on-Wye, UK DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Pre- Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Drug Substance Production SERVICES & CAPABILITIES: controlled substances, generics, non-sterile, ophthalmics, solid dose, topicals "After nearly 20 years, PCI Synthesis has developed a strong sense of where the industry is headed. We recruit great people and continuously train them. We also spend a lot of time delivering what our clients want: 1. Transparency: Communicating so sponsors always know the status of their projects, and with no surprises. 2. Collaboration: Working together keeps projects on a successful trajectory. 3. Expertise: Adding expertise that's complementary to sponsors' in-house capabilities." DRUG TYPE: Pharmaceuticals ED PRICE President CATEGORIES WON: PCI Synthesis Newburyport, MA www.pcisynthesis.com Phone: +1 978 462 5555 Contact: Ed Price Email: ed.price@pcisynthesis.com Key locations: Newburyport, MA; Devens, MA DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: aseptic fill/finish, cartridges, controlled substances, cytotoxic & high potency compounds, injectables, lyophilized prod- ucts, parenterals: small volume, peptides, solid dose, solutions & suspensions, sterile, syringes: pre-filled, highly potent solid oral dose, custom small-molecule API synthesis, small-molecule ste- roid, hormone intermediates, APIs "We're honored to be recognized by pharmaceuti- cal companies big and small. In fact, up to 70 percent of our biopharma partners start out with us as small to mid-sized companies. As a global contract manufacturer embedded within Pfizer, we leverage Pfizer's experience with 600 medi- cines in more than 160 markets on behalf of our biopharmaceutical partners, regardless of their size, while focusing on their individual technical, cultural, and business needs." DRUG TYPE: Pharmaceuticals, Biopharmaceuticals PETER STEVENSON Vice President & General Manager CATEGORIES WON: Pfizer CentreOne New York, NY www.pfizercentreone.com Phone: +1 269 833 2297 Contact: Olivier Roux Email: pfizercentreone@pfizer.com Key locations: Kalamazoo, MI, USA; McPherson, KS, USA; Rocky Mount, NC, USA; Ringaskiddy/ Little Island, Ireland; Newbridge, Ireland; Mel- bourne, Australia INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science INDIVIDUAL ATTRIBUTE AWARDS: right first time, state-of-the-art INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO 2017